Document:

ex10-1.htm

Exhibit 10.1

Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act.  Omitted information, marked “[***]” in this exhibit, has been filed with the Securities and Exchange Commission together with such request for confidential treatment.

AMENDMENT TO

SUPPLY AND DISTRIBUTION AGREEMENT

This Amendment, effective as of January 1, 2013 (the “Effective Date”), modifies the Supply and Distribution Agreement between Heska Corporation (“Heska”) and Boule Medical AB (“Boule”), dated June 17, 2003, hereinafter referred to as “Amendment No. 8”, as modified by Amendment Letter dated June 1, 2004 (hereinafter referred to as “Amendment No. 1”), Amendment Letter dated December 31, 2004 (hereinafter referred to as “Amendment No. 2”), Amendment Letter dated July 12, 2005 (hereinafter referred to as “Amendment No. 3”), Amendment Letter dated March 20, 2007 (hereinafter referred to as “Amendment No. 4”), Amendment Letter dated January 23, 2008 (hereinafter referred to as “Amendment No. 5”), Amendment to Supply and Distribution Agreement effective as of October 1, 2008 (hereinafter referred to as “Amendment No. 6”) and Amendment to Supply and Distribution Agreement effective as of June 1, 2011 (hereinafter referred to as “Amendment No. 7”), collectively referred to as the “Original Agreement”.

	
1.

	
Section 1.2 “Analyzer”, of the Original Agreement is hereby deleted in its entirety and replaced with the following:

	
  

	
1.2 “Analyzer” means the BM800 Veterinary Hematology Analyzer (HemaTrueTM Veterinary Hematology Analyzer) manufactured by Boule or a similar three (3) part veterinary analyzer sold by Boule in the future replacing the BM800 Veterinary Hematology Analyzer or a successor replacement product.  Replacement product will be priced at the same level as its predecessor [***].

	
2.

	
Purchase Minimum. Boule acknowledges Heska has met its minimum purchase obligation for 2011 and 2012.  The minimum purchase commitment for 2013 shall be [***] Analyzers.

	
  

	 

	
3.

	
Appendix A4.  The items on Exhibit 1 are hereby added to Appendix A4 of the Original Agreement, effective November 14, 2011.  To the extent there is a conflict with any item previously listed on Appendix A, the price listed under “New price” on Exhibit 1 shall govern.

	
4.

	
Appendix A5.  Appendix A5 of the Original Agreement is hereby deleted in its entirety and replaced with Appendix A5 attached hereto.

  

1

  

	
5.

	
No Other Changes.  Except as expressly modified by this Amendment No. 8, all other provisions of the Original Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment by their duly authorized representatives.

SIGNED:

Heska Corporation                                                                Boule Medical AB

By: /s/ Jason Napolitano                                                      By:  /s/ Claes Blanche                                                       

Name: Jason Napolitano                                                       Name: Claes Blanche

Title: Chief Financial Officer                                                 Title: Chief Executive Officer

Date: April 15, 2013                                                                Date: May 28th, 2013

  

2

  

Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act.  Omitted information, marked “[***]” in this exhibit, has been filed with the Securities and Exchange Commission together with such request for confidential treatment.

Exhibit 1

Appendix Hematrue spare part price adjustment

	  	  	
  Today price

	
New price

	
1091333_S,

	
TFT display

	
[***]

	
Euro

	
[***]

	
Euro

	
1091323_S,

	
TFT display board

	
[***]

	
Euro

	
[***]

	
Euro

	
1141426_S,

	
TFT Touch

	
[***]

	
Euro

	
[***]

	
Euro

	
1091308_S,

	
Shear Valve

	
[***]

	
Euro

	
[***]

	
Euro

	
1091232_S,

	
MPA

	
[***]

	
Euro

	
[***]

	
Euro

	
1091227_S,

	
MPA handle

	
[***]

	
Euro

	
[***]

	
Euro

	
1091370_S,

	
Valve board

	
[***]

	
Euro

	
[***]

	
Euro

	
1141414_S,

	
Power converter

	
[***]

	
Euro

	
[***]

	
Euro

	
1091317_S,

	
CPU board old

	
[***]

	
Euro

	
[***]

	
Euro

	
1091394_S,

	
CPU board new

	
 

	  	
[***]

	
Euro

	
1120078_S,

	
Power board

	
[***]

	
Euro

	
[***]

	
Euro

	
1141463_S,

	
USB-RS232 conv

	
 

	  	
[***]

	
Euro

	
1090919_S,

	
Level detector

	
[***]

	
Euro

	
[***]

	
Euro

	
1091326_S,

	
RBC chamber

	
[***]

	
Euro

	
[***]

	
Euro

	
1091324_S,

	
WBC chamber

	
[***]

	
Euro

	
[***]

	
Euro

	
1030142_S,

	
Photometer cable

	
[***]

	
Euro

	
[***]

	
Euro

	
1141465_S,

	
BCR USB

	
 

	  	
[***]

	
Euro

	
1091353_S,

	
Level detector yellow

	
[***]

	
Euro

	
[***]

	
Euro

	
1091354_S,

	
Level detector red

	
[***]

	
Euro

	
[***]

	
Euro

	
1091355_S,

	
Level detector blue

	
[***]

	
Euro

	
[***]

	
Euro

	
1091045_S,

	
Inlet Valve

	
[***]

	
Euro

	
[***]

	
Euro

	
1091220

	
Hematrue Front cover

	
[***]

	
Euro

	
[***]

	
Euro

	  	  	  	  	  	  
	
CBC Diff spare parts

	  	  	  	  
	
    9980001

	
Repair kit pump

	
[***]

	
Euro

	
[***]

	
Euro

	
    5306006

	
Gear box Syringe

	
[***]

	
Euro

	
[***]

	
Euro

Above prices are valid from 2011-11-14.

Vӓstberga, Sweden 2011-11-29

/s/ Per Löfbom                                                          

Per Löfbom Service Manager

Boule Medical AB

  

3

  

Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act.  Omitted information, marked “[***]” in this exhibit, has been filed with the Securities and Exchange Commission together with such request for confidential treatment.

Appendix A5

 

This Appendix forms an integrated part of the Supply and Distributorship Agreement between BOULE and HESKA.

 

Heska agrees to make orders of the following Products in units divisible by two.  Payment for fifty percent (50%) of the units in each shipment shall be made in Euros and fifty percent (50%) in U.S. dollars.  The Euro price shall be as listed below, subject to adjustment for actual changes in material and labor costs pursuant to the last paragraph of Section 4.1of the Supply and Distribution Agreement.  The U.S. dollar prices shall be as listed below, subject to adjustment for actual changes in material and labor costs pursuant to the last paragraph of Section 4.1of the Supply and Distribution Agreement.

	
Art no

	
Description

	
Price Net Euro

	
Price Net USD

	  	  	  
	
INSTRUMENTS

	  	  
	
1400060

	
HemaTrueTM Veterinary Hematology Analyzer System with MPA

	
[***]

	
[***]

	  	
[***]

	
[***]

	
[***]

	  	  	  

  

4Nord Resources Corp.: Exhibit 4.4 - Filed by newsfilecorp.com

- 1 -

THIS NOTE HAS NOT BEEN REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OF
THE UNITED STATES, AND IS BEING ISSUED IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE U.S. SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH THE U.S. SECURITIES ACT.

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER
OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE OCTOBER 22,
2013.

GRID PROMISSORY NOTE

	Principal Amount: Up to $238,410.96 	Issue Date: June 21, 2013 
	Due Date: June 21, 2014 	  

For value received the undersigned NORD RESOURCES
CORPORATION (the “Borrower” or the “Company”), a corporation
incorporated under the laws of the State of Delaware with its principal
executive offices located at 1 West Wetmore Rd., Suite 203, Tucson, AZ 85705,
promises to pay to the order of 0864930 B.C. Ltd., (the “Lender” or the
“Holder”), at 1 West Wetmore Rd., Suite 203, Tucson AZ 85705, (or at such
other place as the Lender may designate in writing) the aggregate unpaid
principal balance of each advance made to the Borrower hereunder (each, an
“Advance” and all advances collectively, the “Loan”), together
with any accrued and unpaid interest made by the Lender as set forth on the
books and records of the Lender, which books and records shall constitute
evidence of the Loan absent manifest error, and which books and records shall
include Schedule “A” (the “Grid”) of this grid promissory note (this
“Promissory Note”).

1. The Lender shall advance the Loan to the Borrower as
follows:

	 	(a) 	
      an Advance in the principal amount of $128,410.96 shall
      be made on the issue date of this Promissory Note for the purposes of: (i)
      application by the Borrower of $28,410.96 to payment in full of the
      outstanding principal amount and accrued interest to the date hereof under
      that certain convertible promissory note issued by the Borrower to the
      Lender on July 24, 2012, in the principal amount of $25,000 and bearing
      interest at the rate of 15.0% per annum; and (ii) general working capital
      purposes; and

	 	 	 
	 	(b) 	
      a further Advance in the principal amount of $110,000
      shall be made no later than July 5, 2013.

2. The principal amount of each Advance under the Loan or such
amount thereof as shall remain outstanding from time to time shall bear interest
from and after the date of such Advance at a rate of 20.0% per annum both before
and after each of the Due Date, maturity, default and judgment. Interest shall be calculated
and payable on the Due Date (as defined below).

- 2 -

3. The unpaid principal amount of the Loan and accrued interest
shall be payable in full on the earlier of the closing of a financing
transaction by the Company for gross proceeds in excess of $20,000,000 or June
21, 2014 (the “Due Date”).

4. The Borrower authorizes the Lender to record on the Grid or
on any attachment to this Promissory Note all advances, repayments, prepayments
and the unpaid principal balance from time to time for each Loan. The Borrower
also agrees that in the absence of manifest error, the books and records of the
Lender shall constitute evidence of the Loan and each Advance thereunder whether
or not they are also recorded by the Lender on this Promissory Note or any
attachment, and further provided that the failure of the Lender to record or
correctly record any amount or date shall not affect the obligation of the
Borrower to repay the Loan and interest thereon in accordance with this
Promissory Note.

5. If any payment obligation under this Note is not paid when
due, the remaining unpaid principal balance and any accrued interest shall
become due immediately at the option of the Lender.

6. If any payment obligation under this Note is not paid when
due, the Borrower promises to pay all costs of collection, including reasonable
attorney fees, whether or not a lawsuit is commenced as part of the collection
process.

7. If any of the following events of default occur, this Note
shall become due immediately, without demand or notice:

	 	(a) 	
      The failure of the Borrower to pay the principal and any
      accrued interest in full on or before the Due Date;

	 	 	 
	 	(b) 	
      The filing of bankruptcy proceedings involving the
      Borrower as a debtor;

	 	 	 
	 	(c) 	
      The application for the appointment of a receiver for the
      Borrower;

	 	 	 
	 	(d) 	
      The making of a general assignment for the benefit of the
      Borrower's creditors;

	 	 	 
	 	(e) 	
      The insolvency of the Borrower;

8. If any one or more of the provisions of this Note are
determined to be unenforceable, in whole or in part, for any reason, the
remaining provisions shall remain fully operative.

9. All references to currency in this Note refer to, and all
payments of principal and interest on this Note shall be paid in, the legal
currency of the United States. The Borrower waives presentment for payment,
protest, and notice of protest and nonpayment of this Note.

- 3 -

10. Any notice required or permitted to be given hereunder
shall be given by facsimile transmission or by personal delivery to the party
for whom it is intended, addressed as follows:

	 	(a) 	to the Company at: 
	 	  	  	  
	 	  	1 West Wetmore Rd. 
	 	  	Suite 203 	  
	 	  	Tucson AZ 85705 
	 	  	  	  
	 	  	Attention: 	President and Chief Executive Officer 
	 	  	  	Fax: (520) 292-0268 
	 	  	  	  
		(b) 	to the Holder at its registered
      address as it appears in the records of the Company. 

11. Any notice given pursuant to section 10 shall be deemed to
have been given and received on the date of delivery or, in the case of a
facsimile transmission, at the time indicated on the transmission report. The
Company or the Holder may, from time to time, notify the other in writing of a
change of address which thereafter, until changed by like notice, shall be the
address of the Company or the Holder, as the case may be, for all purposes of
this Note.

12. No renewal or extension of this Note, delay in enforcing
any right of the Lender under this Note, or assignment by Lender of this Note
shall affect the liability or the obligations of the Borrower. All rights of the
Lender under this Note are cumulative and may be exercised concurrently or
consecutively at the Lender's option.

This Note shall be construed in accordance with the laws of the
State of Arizona. Signed this 21st day of June 2013.

Borrower:

	NORD RESOURCES CORPORATION. 
	1 West Wetmore Rd., Suite 203 
	Tucson, Arizona 85705 

	By: 	/s/ Wayne Morrison	 
	  	WAYNE MORRISON 	 
	  	President and Chief Executive
      Officer 	 

Schedule “A”
ADVANCES AND PAYMENTS OF
PRINCIPAL

	
Date 	Amount of
      
Advance 	Amount of
      
Principal Paid 	Unpaid Principal
      
Balance 	
Notation Made by
    
	June 21, 2013 	$128,410.96 	  	128,410.96

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]